LASA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Lasa Supergenerics Ltd. engages in the manufacture of veterinary preparations. It offers veterinary application programming interface products, animal feed ingredients, and reagents for therapeutic use. Its products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Triclabendazole, Rafoxanide, and Ornidazole. The company was founded on March 11, 2016 and is headquartered in Mumbai, India.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
LASA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company